| 863 PROTON PUMP INHIBITOR THERAPY DOES NOT INCREASE THE RISK OF VASCULAR LESIONS ON MRI OR COGNITIVE DECLINE: RESULTS OF A DOUBLE BLIND RANDOMIZED, PLACEBO CONTROLLED COMPASS … P Moayyedi, M Sharma, J Eikelboom, J Bosch, Q Yi, S Yusuf Gastroenterology 166 (5), S-197-S-198, 2024 | | 2024 |
| Perioperative management and outcomes in patients receiving low-dose rivaroxaban and/or aspirin: a subanalysis of the Cardiovascular Outcomes for People Using Anticoagulation … JD Douketis, Q Yi, DL Bhatt, E Muehlhofer, MK Wang, S Connolly, S Yusuf, ... Journal of Thrombosis and Haemostasis, 2024 | | 2024 |
| Clinical significance of new-onset atrial fibrillation in patients with coronary artery or peripheral artery disease: results from the COMPASS trial AP Benz, M Alings, J Bosch, A Avezum, DL Bhatt, JS Healey, LS Johnson, ... Europace 26 (Supplement_1), euae102. 024, 2024 | | 2024 |
| The Effects of Pantoprazole on Kidney Outcomes L Pyne, A Smyth, AO Molnar, P Moayyedi, E Muehlhofer, S Yusuf, ... Journal of the American Society of Nephrology, 10.1681, 2024 | 1 | 2024 |
| The Efficacy and Safety of Andexanet Alfa in Patients With Acute Gastrointestinal Bleeding While Taking Factor Xa Inhibitors: An ANNEXA-4 Subanalysis DM Siegal, N Forbes, J Eikelboom, J Beyer-Westendorf, AT Cohen, L Xu, ... Circulation 149 (16), 1315-1318, 2024 | | 2024 |
| Urinary thromboxane and risk of cardiovascular events: role of aspirin JW Eikelboom, PC Kruger European Heart Journal 45 (15), 1368-1370, 2024 | 1 | 2024 |
| SHOULD FRAIL ELDERLY AF PATIENTS ON VKA SWITCH TO A DOAC? A RANDOMIZED COMPARISON FROM COMBINE-AF, A PATIENT-LEVEL METANALYSIS OF THE 4 LARGE RCTS OF DOACS VS WARFARIN RP Giugliano, A NICOLAU, A Zimerman, J Afilalo, B Gencer, J Steffel, ... Journal of the American College of Cardiology 83 (13_Supplement), 2227-2227, 2024 | | 2024 |
| FRAILTY STATUS AND OUTCOMES IN 58,634 PATIENTS WITH ATRIAL FIBRILLATION RANDOMIZED TO DOAC VS WARFARIN A NICOLAU, J Afilalo, B Gencer, MG Palazzolo, KP Alexander, ... Journal of the American College of Cardiology 83 (13_Supplement), 22-22, 2024 | | 2024 |
| Effect of DOACs versus Warfarin by ASCVD Status in 58,634 Patients with Atrial Fibrillation: A Pooled Analysis of 4 Randomized Trials A Zimerman, MG Palazzolo, SJ Connolly, JW Eikelboom, CB Granger, ... Journal of the American College of Cardiology 83 (13_Supplement), 2288-2288, 2024 | | 2024 |
| Identification Of Atrial Fibrillation Patients With Favorable Outcomes On Warfarin An Individual Patient-Level Analysis Of 29,272 Warfarin Patients from the COMBINE-AF Study S Al Said, E Braunwald, EM Hylek, MG Palazzolo, EM Antman, ... Journal of the American College of Cardiology 83 (13_Supplement), 2289-2289, 2024 | | 2024 |
| Timing of Major Postoperative Bleeding Among Patients Undergoing Surgery ALE Halme, PS Roshanov, SV Tornberg, LI Lavikainen, PJ Devereaux, ... JAMA Network Open 7 (4), e244581-e244581, 2024 | | 2024 |
| Net clinical benefit of extended dual pathway inhibition according to baseline risk in patients with chronic coronary syndrome: a COMPASS substudy M Würtz, KKW Olesen, DL Bhatt, S Yusuf, E Muehlhofer, JW Eikelboom, ... European Heart Journal-Cardiovascular Pharmacotherapy 10 (3), 201-209, 2024 | | 2024 |
| A phase II randomized controlled trial evaluated antithrombotic treatment with fesomersen in patients with kidney failure on hemodialysis WC Winkelmayer, AWA Lensing, RI Thadhani, KW Mahaffey, M Walsh, ... Kidney International, 2024 | 1 | 2024 |
| Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease AH Talasaz, P Sadeghipour, L Ortega-Paz, H Kakavand, ... Nature Reviews Cardiology, 1-19, 2024 | 1 | 2024 |
| Efficacy and Safety of Non–Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta … SM Patel, E Braunwald, J Steffel, G Boriani, MG Palazzolo, EM Antman, ... Circulation 149 (12), 932-943, 2024 | 3 | 2024 |
| Cost-effectiveness of low-dose colchicine in patients with chronic coronary disease in The Netherlands ATL Fiolet, W Keusters, J Blokzijl, SM Nidorf, JW Eikelboom, CA Budgeon, ... European Heart Journal-Quality of Care and Clinical Outcomes, qcae021, 2024 | | 2024 |
| Anticoagulation for mechanical aortic valves: An international survey of current practice patterns and perceptions S Gupta, CC McEwen, W Hou, M Crowther, D Siegal, J Eikelboom, ... Thrombosis Update, 100164, 2024 | | 2024 |
| Optimizing warfarin dosing for patients with atrial fibrillation using machine learning J Petch, W Nelson, M Wu, M Ghassemi, A Benz, M Fatemi, S Di, ... Scientific Reports 14 (1), 4516, 2024 | | 2024 |
| Bleeding outcomes in patients treated with asundexian in phase II trials JW Eikelboom, H Mundl, JH Alexander, V Caso, SJ Connolly, ... Journal of the American College of Cardiology 83 (6), 669-678, 2024 | 2 | 2024 |
| Bleeding Risk in Asian Patients: Potential for Thrombin Amplification Pathway Blockade Using Factor XI Inhibitors Y Liang, Q Yang, J Zhu, J Eikelboom JACC: Asia 4 (2), 163-165, 2024 | | 2024 |
Graeme J. HankeyPerron Institute Chair in Stroke Research, The University of Western Australia在 uwa.edu.au 的电子邮件经过验证
